Prof. Rong Ma 马荣
Chief Physician, Professor
Department of Gynecology, Harbin Medical University Cancer Hospital, Harbin
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Diagnosis and comprehensive treatment of gynecologic tumors, including ovarian, cervical, endometrial, vulvar cancers, gestational trophoblastic disease, cervical diseases, uterine fibroids, and endometriosis.
Dr. Ma is a Chief Physician, Professor, and Head of the Second Gynecology Ward at Harbin Medical University Cancer Hospital. Dr. Ma holds a medical doctorate and completed postdoctoral training in biology and in the United States. Dr. Ma was named a Longjiang Famous Doctor in 2022 and approved as a doctoral supervisor in 2020.
Name order: in Chinese the family name comes first (Ma Rong). Papers usually list the name as Rong Ma or Ma R.
Selected publications
28 papers on PubMed matched by name and affiliation; 13 as first or senior author since 2016. Most recent first- or senior-author papers:
- Int J Biol Macromol, 2026 (senior author): Retraction notice to "Development of novel prognostic protein signatures in ovarian cancer: Molecular structure and immune function of AQP5 protein and CTDP1 protein" [Int. J. Biol. Macromol. 310 (2025) 143474]. PubMed 42486759
- Oncogene, 2026 (senior author): SLC7A5-ERBB2 axis drives olaparib resistance via de novo lipid synthesis in ovarian cancer. PubMed 41315667
- Cell Death Dis, 2025 (senior author): Unveiling the ZNF384-INTS13-hnRNPC axis as a therapeutic vulnerability in cervical cancer. PubMed 41429980
- Mol Cancer, 2025 (senior author): Advances in RNA-based cancer therapeutics: pre-clinical and clinical implications. PubMed 41068915
- Int J Biol Macromol, 2025 (senior author): Development of novel prognostic protein signatures in ovarian cancer: Molecular structure and immune function of AQP5 protein and CTDP1 protein. PubMed 40286746
- Reproduction, 2024 (senior author): ZNF146 regulates cell cycle progression via TFDP1 and DEPDC1B in ovarian cancer cells. PubMed 38614125
- Cell Biochem Biophys, 2024 (senior author): XTP8 Promotes Ovarian Cancer Progression by Activating AKT/AMPK/mTOR Pathway to Regulate EMT. PubMed 38717641
- Oncologist, 2022 (senior author): GBAS Regulates the Proliferation and Metastasis of Ovarian Cancer Cells by Combining with eEF1A1. PubMed 35305106
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that the papers match this doctor's specialty; this check is automatic.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion